🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unlicensed Weight-Loss Medication A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations. Experimental Drug Acquiring Traction Online Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes. Active Trade on Messaging Platforms Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions. Understanding The Experimental Drug Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic. Medical Experts Express Worries However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin. Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro. Legal Status and Enforcement Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison. Service Reaction and Content Removal Based on the social media company, the service has removed violative content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies. Online Trading Activities Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at home. Within minutes of entering one community, a vendor posted contact information, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience. Item Details and Pricing Within these groups, messages display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”. Service Moderation and Safety Actions A representative for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Warnings “Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service. A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained. Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.” Producer Position A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious medical dangers”.